Wedgewood Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- Wedgewood Pharmacy's estimated annual revenue is currently $168M per year.
- Wedgewood Pharmacy's estimated revenue per employee is $201,000
Employee Data
- Wedgewood Pharmacy has 836 Employees.
- Wedgewood Pharmacy grew their employee count by 29% last year.
Wedgewood Pharmacy's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP - Government and Regulatory Affairs | Reveal Email/Phone |
3 | SVP Equine & Special Markets | Reveal Email/Phone |
4 | Head Customer Care | Reveal Email/Phone |
5 | VP Pharmacy and Pharmacist in Charge | Reveal Email/Phone |
6 | SVP, Supply Chain Operations | Reveal Email/Phone |
7 | General Counsel | Reveal Email/Phone |
8 | VP, National Sales | Reveal Email/Phone |
9 | Controller | Reveal Email/Phone |
10 | VP Finance and Accounting | Reveal Email/Phone |
Wedgewood Pharmacy Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Wedgewood Pharmacy?
Drug Stores & Pharmacies
keywords:N/A
N/A
Total Funding
836
Number of Employees
$168M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Wedgewood Pharmacy News
2022-04-13 - Compounding Pharmacy Market MAY SEE A BIG MOVE ...
Wedgewood Pharma; Clinigen Group; Braun Medical; PharMEDium Services; McKesson Corporation; Dougherty's Pharmacy; Village Compounding Pharmacy...
2016-06-09 - Wedgewood Pharmacy Receives Majority Equity Investment from New Harbor Capital
Wedgewood Pharmacy, a Swedesboro, N.J.-based compounding pharmacy specializing in animal health, addiction medicine and urology, received a majority equity investment from Chicago-based New Harbor Capital. The amount of the deal was not disclosed. In conjunction with the transaction, Lucy Malm ...